Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 54, Issue 12, Pages 4006-4017Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm2000689
Keywords
-
Categories
Funding
- Associazione Italiana per la Ricerca sul Cancro (AIRC) [6266]
- Asinex
Ask authors/readers for more resources
Cytochrome P450 aromatase catalyzes the conversion of androgen substrates into estrogens. Aromatase inhibitors (AIs) have been used as first-line drugs in the treatment of estrogen-dependent breast cancer in postmenopausal women. However, the search for new, more potent, and selective AIs still remains necessary to avoid the risk of possible resistances and reduce toxicity and side effects of current available drugs. The publication of a high resolution X-ray structure of human aromatase has opened the way to structure-based virtual screening to identify new small-molecule inhibitors with structural motifs different from all known AIs. In this context, a high-throughput docking protocol was set up and led to the identification of nanomolar AIs with new core structures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available